ICD-10-CM Code C79.2 Secondary malignant neoplasm of skin. C79.2 is a billable ICD code used to specify a diagnosis of secondary malignant neoplasm of skin. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Secondary malignant neoplasm of skin 2016 2017 2018 2019 2020 2021 Billable/Specific Code C79.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM C79.2 became effective on October 1, 2020.
Secondary malignant neoplasm of skin. The spread of the cancer to the skin. This may be from a primary skin cancer, or from a cancer at a distant site.
C79 ICD-10-CM Diagnosis Code C79. Secondary malignant neoplasm of other and unspecified sites 2016 2017 2018 2019 Non-Billable/Non-Specific Code. Type 1 Excludes secondary carcinoid tumors (C7B.-) secondary neuroendocrine tumors (C7B.-) Secondary malignant neoplasm of other and unspecified sites.
Type-1 Excludes mean the conditions excluded are mutually exclusive and should never be coded together. Excludes 1 means "do not code here."
The ICD-10-CM Neoplasms Index links the below-listed medical terms to the ICD code C79.2. Click on any term below to browse the neoplasms index.
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 198.2 was previously used, C79.2 is the appropriate modern ICD10 code.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Other specified malignant neoplasm of skin of right lower limb, including hip 1 C44.792 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Oth malignant neoplasm skin/ right lower limb, including hip 3 The 2021 edition of ICD-10-CM C44.792 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of C44.792 - other international versions of ICD-10 C44.792 may differ.
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
secondary carcinoid tumors ( C 7B.-) secondary neuroendocrine tumors ( C7B.-) Cancer that has spread from the original (primary) tumor to the bone.